30 Years of Evidence
Take a moment to explore a selection of publications and conference abstracts from around the globe. Find evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and real-time motion synchronization techniques for the CyberKnife® and Radixact®/ TomoTherapy® platforms. We update new papers on a regular basis. See how health professionals are helping to improve patient outcomes.
Featured Content
PROSTATE cancer
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRT
Date: 2025
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Andrei Fodor et al.
SPINAL CANCER
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
Date: 2025
Treatment Technique: SBRT
Platform: CyberKnife System
Author: David J Park et al.
BREAST CANCER
Ablative Preoperative Single-Fraction Radiation Dose Escalation Among Patients With Breast Cancer: A Phase 1 Nonrandomized Clinical Trial
Date: 2025
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Asal Rahimi et al.
Single-fraction SBRT with Radixact for lung malignancies: early outcomes of a single-center experience
Francesco Cuccia, Italy | ESTRO | 2026
Early post-SBRT CT patterns and dosimetric factors predict recurrence in solitary lung nodules
María Pagola | ESTRO | 2026
Dosimetric evaluation of real-time adaptive radiotherapy with Radixact® Synchrony® for lung carcinoma
Gaetano Gagliardo, Italy | ESTRO | 2026
Online adaptive radiotherapy using integrated vendor platforms: workflow timings using Radixact® and Raystation.
Samira Shire, United Kingdom | ESTRO | 2026
Development and implementation of online adaptive radiotherapy (oART) using a Radixact delivery platform in combination with the RayStation TPS
Irena Blasiak-Wal, United Kingdom | ESTRO | 2026
Hypofractionated preoperative radiotherapy in soft tissue sarcoma of the extremities andtrunk: outcomes from a prospective phase II study
Anastasia Stergioula | ESTRO | 2026
Stereotactic radiotherapy for non-spine bone metastases: a mono-institutional experience
Francesco Cuccia | ESTRO | 2026
Initial clinical experience of RayStation-based online adaptive RT using Radixact for endometrial cancer.
Irena Blasiak-Wal, United Kingdom | ESTRO | 2026
Single-fraction SBRT with Radixact for lung malignancies: early outcomes of a single-center experience
Francesco Cuccia, Italy | ESTRO | 2026
Early post-SBRT CT patterns and dosimetric factors predict recurrence in solitary lung nodules
María Pagola | ESTRO | 2026
Dosimetric evaluation of real-time adaptive radiotherapy with Radixact® Synchrony® for lung carcinoma
Gaetano Gagliardo, Italy | ESTRO | 2026
Online adaptive radiotherapy using integrated vendor platforms: workflow timings using Radixact® and Raystation.
Samira Shire, United Kingdom | ESTRO | 2026
Development and implementation of online adaptive radiotherapy (oART) using a Radixact delivery platform in combination with the RayStation TPS
Irena Blasiak-Wal, United Kingdom | ESTRO | 2026
Hypofractionated preoperative radiotherapy in soft tissue sarcoma of the extremities andtrunk: outcomes from a prospective phase II study
Anastasia Stergioula | ESTRO | 2026
Stereotactic radiotherapy for non-spine bone metastases: a mono-institutional experience
Francesco Cuccia | ESTRO | 2026
Interested in conducting research with the CyberKnife® or Radixact® / TomoTherapy® Systems?
If you’re a member of Accuray Exchange (AEx), you can complete a collaboration application form here.